PortfoliosLab logoPortfoliosLab logo
GN0M.DE vs. WELP.DE
Performance
Return for Risk
Drawdowns
Volatility
Dividends

Performance

GN0M.DE vs. WELP.DE - Performance Comparison

The chart below illustrates the hypothetical performance of a €10,000 investment in Global X Genomics & Biotechnology UCITS ETF (GN0M.DE) and HANetf HAN-GINS Indxx Healthcare Megatrend Equal Weight UCITS ETF (WELP.DE). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, GN0M.DE achieves a 21.92% return, which is significantly lower than WELP.DE's 25.35% return.


GN0M.DE

1D
0.00%
1M
17.82%
YTD
21.92%
6M
19.50%
1Y
69.41%
3Y*
2.84%
5Y*
10Y*

WELP.DE

1D
0.00%
1M
-7.19%
YTD
25.35%
6M
26.72%
1Y
34.31%
3Y*
12.49%
5Y*
10Y*
*Multi-year figures are annualized to reflect compound growth (CAGR)

GN0M.DE vs. WELP.DE - Yearly Performance Comparison


2026 (YTD)2025202420232022
GN0M.DE
Global X Genomics & Biotechnology UCITS ETF
21.92%5.67%-12.40%-9.04%-11.46%
WELP.DE
HANetf HAN-GINS Indxx Healthcare Megatrend Equal Weight UCITS ETF
25.35%-1.54%7.90%0.25%5.34%

Correlation

The correlation between GN0M.DE and WELP.DE is -0.13, meaning they tend to move in opposite directions. This is especially valuable for risk management - when one declines, the other has historically tended to hold steady or rise.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

-0.13

Correlation (3Y)
Calculated over the trailing 3-year period

0.10

Correlation (All Time)
Calculated using the full available price history since Sep 20, 2022

0.13

The correlation between GN0M.DE and WELP.DE shifts across timeframes, from -0.13 (1 year) to 0.13 (all time), reflecting how their relationship changes across market environments.

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

GN0M.DE vs. WELP.DE — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

GN0M.DE
GN0M.DE Risk / Return Rank: 8080
Overall Rank
GN0M.DE Sharpe Ratio Rank: 8787
Sharpe Ratio Rank
GN0M.DE Sortino Ratio Rank: 8686
Sortino Ratio Rank
GN0M.DE Omega Ratio Rank: 7676
Omega Ratio Rank
GN0M.DE Calmar Ratio Rank: 8686
Calmar Ratio Rank
GN0M.DE Martin Ratio Rank: 6666
Martin Ratio Rank

WELP.DE
WELP.DE Risk / Return Rank: 5757
Overall Rank
WELP.DE Sharpe Ratio Rank: 5959
Sharpe Ratio Rank
WELP.DE Sortino Ratio Rank: 5252
Sortino Ratio Rank
WELP.DE Omega Ratio Rank: 5555
Omega Ratio Rank
WELP.DE Calmar Ratio Rank: 6464
Calmar Ratio Rank
WELP.DE Martin Ratio Rank: 5555
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

GN0M.DE vs. WELP.DE - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Global X Genomics & Biotechnology UCITS ETF (GN0M.DE) and HANetf HAN-GINS Indxx Healthcare Megatrend Equal Weight UCITS ETF (WELP.DE). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


GN0M.DEWELP.DEDifference
Sharpe ratioReturn per unit of total volatility

+0.73

Sortino ratioReturn per unit of downside risk

+1.10

Omega ratioGain probability vs. loss probability

1.39

1.31

+0.09

Calmar ratioReturn relative to maximum drawdown

4.18

2.80

+1.39

Martin ratioReturn relative to average drawdown

10.59

8.57

+2.02

GN0M.DE vs. WELP.DE - Sharpe Ratio Comparison

The current GN0M.DE Sharpe Ratio is 2.48, which is higher than the WELP.DE Sharpe Ratio of 1.75. The chart below compares the historical Sharpe Ratios of GN0M.DE and WELP.DE, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Drawdowns

GN0M.DE vs. WELP.DE - Drawdown Comparison

The maximum GN0M.DE drawdown since its inception was -67.19%, which is greater than WELP.DE's maximum drawdown of -23.55%. Use the drawdown chart below to compare losses from any high point for GN0M.DE and WELP.DE.


Loading charts...

Drawdown Indicators


GN0M.DEWELP.DEDifference

Max Drawdown

Largest peak-to-trough decline

-67.19%

-23.55%

-43.64%

Max Drawdown (1Y)

Largest decline over 1 year

-16.68%

-12.22%

-4.46%

Max Drawdown (3Y)

Largest decline over 3 years

-45.68%

-23.55%

-22.13%

Current Drawdown

Current decline from peak

-36.37%

-11.07%

-25.30%

Average Drawdown

Average peak-to-trough decline

-43.06%

-7.79%

-35.27%

Ulcer Index

Depth and duration of drawdowns from previous peaks

6.58%

3.99%

+2.59%

Volatility

GN0M.DE vs. WELP.DE - Volatility Comparison

Global X Genomics & Biotechnology UCITS ETF (GN0M.DE) has a higher volatility of 9.66% compared to HANetf HAN-GINS Indxx Healthcare Megatrend Equal Weight UCITS ETF (WELP.DE) at 6.59%. This indicates that GN0M.DE's price experiences larger fluctuations and is considered to be riskier than WELP.DE based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


GN0M.DEWELP.DEDifference

Volatility (1M)

Calculated over the trailing 1-month period

9.66%

6.59%

+3.07%

Volatility (6M)

Calculated over the trailing 6-month period

20.37%

16.90%

+3.47%

Volatility (1Y)

Calculated over the trailing 1-year period

28.15%

19.54%

+8.61%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

31.45%

20.07%

+11.38%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

31.45%

20.07%

+11.38%

GN0M.DE vs. WELP.DE - Expense Ratio Comparison

GN0M.DE has a 0.50% expense ratio, which is lower than WELP.DE's 0.59% expense ratio.


Dividends

GN0M.DE vs. WELP.DE - Dividend Comparison

GN0M.DE has not paid dividends to shareholders, while WELP.DE's dividend yield for the trailing twelve months is around 3.05%.


PositionTTM202520242023
GN0M.DE
Global X Genomics & Biotechnology UCITS ETF
0.00%0.00%0.00%0.00%
WELP.DE
HANetf HAN-GINS Indxx Healthcare Megatrend Equal Weight UCITS ETF
3.05%3.78%3.64%0.79%

Frequently Asked Questions


GN0M.DE and WELP.DE have a correlation of -0.13, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

On fees, GN0M.DE is cheaper at 0.50% per year. The better choice depends on whether you care most about return, fees, risk, or income.

GN0M.DE is cheaper with a 0.50% expense ratio, compared with 0.59% for WELP.DE.

GN0M.DE tracks Solactive Genomics, while WELP.DE tracks MSCI World/Energy NR USD. They also come from different issuers: Global X and Amundi. Their fees differ too: 0.50% for GN0M.DE and 0.59% for WELP.DE.

Portfolio Optimizer

Find the right allocation for GN0M.DE and WELP.DE

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer